Cargando…
SEROUS MACULAR DETACHMENT ASSOCIATED WITH WALDENSTROM MACROGLOBULINEMIA MANAGED WITH IBRUTINIB: A CASE REPORT AND NEW INSIGHTS INTO PATHOGENESIS
PURPOSE: To report a case of serous macular detachment in a patient with Waldenstrom macroglobulinemia treated with ibrutinib. METHODS: The patient underwent a complete ophthalmic examination and imaging at presentation and at follow-up visits up to 13 months. RESULTS: At presentation, there were se...
Autores principales: | Leskov, Ilya, Knezevic, Alexander, Gill, Manjot K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Retinal Cases & Brief Reports
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219087/ https://www.ncbi.nlm.nih.gov/pubmed/30531550 http://dx.doi.org/10.1097/ICB.0000000000000837 |
Ejemplares similares
-
Evaluating ibrutinib in the treatment of symptomatic Waldenstrom’s macroglobulinemia
por: Papanota, Aristea-Maria, et al.
Publicado: (2019) -
Ibrutinib-Induced Pancreatitis in Patients with Waldenstrom Macroglobulinemia
por: Büyükkurt, Nurhilal, et al.
Publicado: (2023) -
What the Silent Retina Tells You: Serous Retinal Detachment in Waldenström’s Macroglobulinemia
por: Amaador, Karima, et al.
Publicado: (2021) -
Cost-effectiveness analysis of ibrutinib in patients with Waldenström macroglobulinemia in Italy
por: Aiello, Andrea, et al.
Publicado: (2017) -
PB2074: IBRUTINIB AS A PROMISING TREATMENT FOR WALDENSTRÖM MACROGLOBULINEMIA
por: Ilhan, O., et al.
Publicado: (2022)